Inovio Biomedical To Present At International DNA Vaccine Conference

Main Category: Immune System / Vaccines
Also Included In: Conferences;  Genetics
Article Date: 06 Jul 2009 - 5:00 PDT

email to a friend   printer friendly   opinions  

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it will make multiple presentations at the Annual Conference of DNA Vaccines in Asia 2009 being hosted by the International Society of DNA Vaccines July 9 - 10 at the Beijing International Convention Center. The conference, with the theme, "Advancing DNA Vaccine Technology," is co-chaired by David B. Weiner, Ph.D., professor of pathology, University of Pennsylvania School of Medicine, and chairman of Inovio's scientific advisory board.

Inovio scientists and associates will be making the following presentations:

Engineering Highly Immune Potent DNA Vaccines by Engineering Molecular Biology, Immunology and Physical Delivery In Vivo
Presidential Address and Keynote Lecture

David B. Weiner, Ph.D.
Thursday July 9
08:30 - 09:05
Location: 305BC

Immune Therapy by Electroporation
Plenary Session 2
Iacob Mathiesen, Ph.D., Managing Director, Inovio AS
Thursday July 9
11:00 - 12:10
Location: 305BC

Pandemic and Seasonal Influenza DNA Vaccines Delivered via Electroporation
Plenary Session 3
Niranjan Y. Sardesai, Ph.D., Sr. VP, Research & Development, Inovio Biomedical
Thursday July 9
13:10 - 14:55
Location: 305BC

Special Considerations for Multi-Component DNA Vaccine Production
Plenary Session 7
Henry Hebel, Chief Operating Officer, VGXI Inc.
Friday July 10
11:00 - 12:10
Location: 305BC

Source
Inovio Biomedical Corporation

• Additional
• References
• Citations